Ignite Creation Date:
2025-12-24 @ 1:37 PM
Ignite Modification Date:
2025-12-28 @ 8:25 PM
Study NCT ID:
NCT01656395
Status:
TERMINATED
Last Update Posted:
2018-09-13
First Post:
2012-07-03
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-08-23
Start Date Type:
ACTUAL
Primary Completion Date:
2014-06-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-07-08
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-03
First Submit QC Date:
None
Study First Post Date:
2012-08-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-07-12
Results First Submit QC Date:
None
Results First Post Date:
2018-09-13
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-15
Last Update Post Date:
2018-09-13
Last Update Post Date Type:
ACTUAL